PROGEN.ST
Prostatype Genomics AB
Price:  
10.90 
SEK
Volume:  
25,207.00
Sweden | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PROGEN.ST Fair Value

-461.10 %
Upside

As of 2024-12-15, the Fair Value of Prostatype Genomics AB (PROGEN.ST) is -39.36 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.90 SEK, the upside of Prostatype Genomics AB is -461.10%.

Note: valuation result may not be accurate due to the company's negative EPS.

10.90 SEK
Stock Price
-39.36 SEK
Fair Price
FAIR VALUE CALCULATION

PROGEN.ST Fair Value

Peter Lynch's formula is:

PROGEN.ST Fair Value
= Earnings Growth Rate x TTM EPS
PROGEN.ST Fair Value
= 5.00 x -7.87
PROGEN.ST Fair Value
= -39.36

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-06-30 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -8.55 -17.41 -15.63 -29.09 -41.44 -22.42
YoY growth 8.26% -103.63% 10.22% -86.09% -42.45% -42.74%

PROGEN.ST Fair Value - Key Data

Market Cap (mil) 56.14
P/E
Forward P/E
EPS -7.87
Avg earnings growth rate -42.74%
TTM earnings -40.54